tiprankstipranks
CME Group (MX:CME)
:CME
Mexico Market

CME Group (CME) Ratios

0 Followers

CME Group Ratios

MX:CME's free cash flow for Q2 2026 was $0.69. For the 2026 fiscal year, MX:CME's free cash flow was decreased by $ and operating cash flow was $0.51. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.02 92.97 1.01 1.02 1.01
Quick Ratio
1.02 92.97 1.01 1.02 1.01
Cash Ratio
0.01 79.27 0.03 0.03 0.02
Solvency Ratio
0.03 0.03 0.03 0.03 0.02
Operating Cash Flow Ratio
0.03 76.65 0.04 0.04 0.02
Short-Term Operating Cash Flow Coverage
0.00 76.65 4.92 0.00 191.00
Net Current Asset Value
$ -6.59B$ -164.63B$ -7.93B$ -8.08B$ -8.22B
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.02 0.03 0.02
Debt-to-Equity Ratio
0.13 0.13 0.13 0.13 0.13
Debt-to-Capital Ratio
0.11 0.12 0.11 0.11 0.11
Long-Term Debt-to-Capital Ratio
0.11 0.11 0.09 0.11 0.11
Financial Leverage Ratio
7.34 6.91 5.19 4.85 6.48
Debt Service Coverage Ratio
46.11 23.97 4.42 23.45 18.00
Interest Coverage Ratio
50.27 32.61 24.43 21.55 18.54
Debt to Market Cap
0.03 0.04 0.04 0.05 0.06
Interest Debt Per Share
9.76 10.81 9.99 9.98 10.04
Net Debt to EBITDA
0.24 -0.12 0.11 0.11 0.18
Profitability Margins
Gross Profit Margin
81.89%86.09%86.13%85.15%85.00%
EBIT Margin
76.80%83.51%76.71%77.31%72.78%
EBITDA Margin
79.23%87.73%82.20%83.63%80.00%
Operating Profit Margin
65.10%64.86%64.13%61.58%60.08%
Pretax Profit Margin
82.60%81.75%74.08%74.45%69.54%
Net Profit Margin
63.08%62.02%57.52%57.83%53.61%
Continuous Operations Profit Margin
63.08%62.22%57.52%57.83%53.61%
Net Income Per EBT
76.37%75.87%77.64%77.67%77.10%
EBT Per EBIT
126.88%126.03%115.51%120.90%115.73%
Return on Assets (ROA)
2.19%2.04%2.57%2.49%1.54%
Return on Equity (ROE)
15.53%14.08%13.31%12.07%10.01%
Return on Capital Employed (ROCE)
12.28%2.13%11.19%9.47%8.27%
Return on Invested Capital (ROIC)
9.38%1.62%8.51%7.35%6.37%
Return on Tangible Assets
2.56%2.40%3.30%3.26%1.88%
Earnings Yield
4.22%4.12%4.22%4.27%4.46%
Efficiency Ratios
Receivables Turnover
8.99 10.20 10.70 10.42 10.39
Payables Turnover
18.04 12.63 10.64 9.15 6.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
19.28 11.38 15.87 13.62 11.02
Asset Turnover
0.03 0.03 0.04 0.04 0.03
Working Capital Turnover Ratio
2.32 2.23 5.59 3.90 3.64
Cash Conversion Cycle
20.35 6.89 -0.17 -4.87 -23.70
Days of Sales Outstanding
40.59 35.78 34.12 35.04 35.14
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
20.24 28.89 34.30 39.91 58.84
Operating Cycle
40.59 35.78 34.12 35.04 35.14
Cash Flow Ratios
Operating Cash Flow Per Share
11.97 11.89 10.27 9.62 8.52
Free Cash Flow Per Share
11.70 11.66 10.01 9.41 8.27
CapEx Per Share
0.27 0.23 0.26 0.21 0.25
Free Cash Flow to Operating Cash Flow
0.98 0.98 0.97 0.98 0.97
Dividend Paid and CapEx Coverage Ratio
1.03 1.06 1.00 1.04 1.12
Capital Expenditure Coverage Ratio
44.75 51.22 39.26 45.21 34.07
Operating Cash Flow Coverage Ratio
1.26 1.14 1.08 1.01 0.89
Operating Cash Flow to Sales Ratio
0.64 0.66 0.60 0.62 0.61
Free Cash Flow Yield
4.16%4.27%4.31%4.47%4.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.74 24.43 23.67 23.44 22.42
Price-to-Sales (P/S) Ratio
14.93 15.06 13.61 13.55 12.02
Price-to-Book (P/B) Ratio
3.82 3.42 3.15 2.83 2.24
Price-to-Free Cash Flow (P/FCF) Ratio
24.01 23.42 23.21 22.39 20.34
Price-to-Operating Cash Flow Ratio
23.50 22.96 22.62 21.89 19.74
Price-to-Earnings Growth (PEG) Ratio
1.64 1.59 2.56 1.19 14.88
Price-to-Fair Value
3.82 3.42 3.15 2.83 2.24
Enterprise Value Multiple
19.09 17.05 16.67 16.32 15.20
Enterprise Value
102.43B 97.54B 84.00B 76.12B 61.04B
EV to EBITDA
19.09 17.05 16.67 16.32 15.20
EV to Sales
15.12 14.96 13.70 13.64 12.16
EV to Free Cash Flow
24.31 23.26 23.36 22.54 20.58
EV to Operating Cash Flow
23.77 22.81 22.76 22.04 19.97
Tangible Book Value Per Share
-3.41 -4.37 -11.12 -11.09 -11.29
Shareholders’ Equity Per Share
73.67 79.88 73.70 74.47 74.93
Tax and Other Ratios
Effective Tax Rate
0.24 0.24 0.22 0.22 0.23
Revenue Per Share
18.81 18.13 17.06 15.54 13.99
Net Income Per Share
11.87 11.25 9.81 8.99 7.50
Tax Burden
0.76 0.76 0.78 0.78 0.77
Interest Burden
1.08 0.98 0.97 0.96 0.96
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.02 0.02 0.02 0.03 0.03
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.01 0.02
Income Quality
1.01 1.05 1.05 1.07 1.14
Currency in USD